Quick Links
About MyAmyloidosisTeam
Powered By
Clinical Trial
I received this information on ni006, which shows signs of removing Attr amyloid from the system. Phase I was completed earlier this year.
“The drug is moving directly to Phase 3 studies
A phase 3 trial will begin by the end of the year/beginning 2024. The company who has acquired the drug and is running the phase 3 is Alexion.
Enrollment for the Phase 3 trial will be worldwide including the US. I recommend to contact alexion US or a local specialist in cardiac amyloidosis to identify a… read more
i am not eligible because o have sclerosis of the liver
Thanks for the information God Bless
There’s some hopeful treatments on the horizon. Prayers that they’re approved and affordable!
Seems that it is European:
https://clinicaltrials.gov/study/NCT04360434?in...
https://www.nejm.org/doi/full/10.1056/NEJMc(Phone number can only be seen by the question and answer creators)?query=recirc_curatedRelated_article
I Am Wondering If I Should Continue To Take Tafamidis As I Am In Stage Iiib Advanced Heart Failure?
I Just Finished My Three Year Clinical Trial With Helios B,, Anyone Else In This Form That Has Undergone This Trial With Helios B/Vutrisiran
Has Anyone Found That Post-clinical Trial, Their Symptoms Worsen?`
Sign up for free!
Continue with Facebook
Sign up with your email
